Preeclampsia

An Obstetrician's Perspective

Mary L. Rosser, Nadine T. Katz

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Preeclampsia is a pregnancy-specific syndrome that usually develops after 20 weeks gestation. The exact pathogenic mechanisms remain uncertain and are likely multifactorial. Preeclampsia is a heterogeneous condition with potentially maternal and fetal consequences. As part of the spectrum of hypertensive disorders of pregnancy, preeclampsia may progress rapidly and is a leading cause of maternal and perinatal morbidity and mortality worldwide. In the United States, the incidence of preeclampsia has increased. Clinical manifestations are highly variable and may occur antepartum, intrapartum, or postpartum. Hypertension and proteinuria are the traditional hallmarks for the diagnosis of preeclampsia. These signs may occur with or without multisystem dysfunction and fetal involvement. Risk factors have been identified for the development of preeclampsia; however, ideal methods for prevention, screening, and treatment remain elusive. Preeclampsia resolves after delivery of the fetus, but patients may still have hypertension postpartum. Women and fetuses affected by preeclampsia are at higher risk of developing long-term health issues. There appear to be risk factors common to hypertensive disorders of pregnancy and cardiovascular disease seen later in adulthood. Physicians providing healthcare to women are urged to recognize potential risk factors that arise from patient obstetric histories so that optimal long-term health surveillance is provided.

Original languageEnglish (US)
Pages (from-to)287-296
Number of pages10
JournalAdvances in Chronic Kidney Disease
Volume20
Issue number3
DOIs
StatePublished - May 2013

Fingerprint

Pre-Eclampsia
Pregnancy
Postpartum Period
Fetus
Mothers
Hypertension
Perinatal Mortality
Health
Proteinuria
Obstetrics
Cardiovascular Diseases
Morbidity
Delivery of Health Care
Physicians
Incidence

Keywords

  • Cardiovascular disease
  • Hypertension
  • Preeclampsia
  • Pregnancy
  • Prevention

ASJC Scopus subject areas

  • Nephrology

Cite this

Preeclampsia : An Obstetrician's Perspective. / Rosser, Mary L.; Katz, Nadine T.

In: Advances in Chronic Kidney Disease, Vol. 20, No. 3, 05.2013, p. 287-296.

Research output: Contribution to journalArticle

@article{c803bf9d50e2487197454fbfef59f287,
title = "Preeclampsia: An Obstetrician's Perspective",
abstract = "Preeclampsia is a pregnancy-specific syndrome that usually develops after 20 weeks gestation. The exact pathogenic mechanisms remain uncertain and are likely multifactorial. Preeclampsia is a heterogeneous condition with potentially maternal and fetal consequences. As part of the spectrum of hypertensive disorders of pregnancy, preeclampsia may progress rapidly and is a leading cause of maternal and perinatal morbidity and mortality worldwide. In the United States, the incidence of preeclampsia has increased. Clinical manifestations are highly variable and may occur antepartum, intrapartum, or postpartum. Hypertension and proteinuria are the traditional hallmarks for the diagnosis of preeclampsia. These signs may occur with or without multisystem dysfunction and fetal involvement. Risk factors have been identified for the development of preeclampsia; however, ideal methods for prevention, screening, and treatment remain elusive. Preeclampsia resolves after delivery of the fetus, but patients may still have hypertension postpartum. Women and fetuses affected by preeclampsia are at higher risk of developing long-term health issues. There appear to be risk factors common to hypertensive disorders of pregnancy and cardiovascular disease seen later in adulthood. Physicians providing healthcare to women are urged to recognize potential risk factors that arise from patient obstetric histories so that optimal long-term health surveillance is provided.",
keywords = "Cardiovascular disease, Hypertension, Preeclampsia, Pregnancy, Prevention",
author = "Rosser, {Mary L.} and Katz, {Nadine T.}",
year = "2013",
month = "5",
doi = "10.1053/j.ackd.2013.02.005",
language = "English (US)",
volume = "20",
pages = "287--296",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Preeclampsia

T2 - An Obstetrician's Perspective

AU - Rosser, Mary L.

AU - Katz, Nadine T.

PY - 2013/5

Y1 - 2013/5

N2 - Preeclampsia is a pregnancy-specific syndrome that usually develops after 20 weeks gestation. The exact pathogenic mechanisms remain uncertain and are likely multifactorial. Preeclampsia is a heterogeneous condition with potentially maternal and fetal consequences. As part of the spectrum of hypertensive disorders of pregnancy, preeclampsia may progress rapidly and is a leading cause of maternal and perinatal morbidity and mortality worldwide. In the United States, the incidence of preeclampsia has increased. Clinical manifestations are highly variable and may occur antepartum, intrapartum, or postpartum. Hypertension and proteinuria are the traditional hallmarks for the diagnosis of preeclampsia. These signs may occur with or without multisystem dysfunction and fetal involvement. Risk factors have been identified for the development of preeclampsia; however, ideal methods for prevention, screening, and treatment remain elusive. Preeclampsia resolves after delivery of the fetus, but patients may still have hypertension postpartum. Women and fetuses affected by preeclampsia are at higher risk of developing long-term health issues. There appear to be risk factors common to hypertensive disorders of pregnancy and cardiovascular disease seen later in adulthood. Physicians providing healthcare to women are urged to recognize potential risk factors that arise from patient obstetric histories so that optimal long-term health surveillance is provided.

AB - Preeclampsia is a pregnancy-specific syndrome that usually develops after 20 weeks gestation. The exact pathogenic mechanisms remain uncertain and are likely multifactorial. Preeclampsia is a heterogeneous condition with potentially maternal and fetal consequences. As part of the spectrum of hypertensive disorders of pregnancy, preeclampsia may progress rapidly and is a leading cause of maternal and perinatal morbidity and mortality worldwide. In the United States, the incidence of preeclampsia has increased. Clinical manifestations are highly variable and may occur antepartum, intrapartum, or postpartum. Hypertension and proteinuria are the traditional hallmarks for the diagnosis of preeclampsia. These signs may occur with or without multisystem dysfunction and fetal involvement. Risk factors have been identified for the development of preeclampsia; however, ideal methods for prevention, screening, and treatment remain elusive. Preeclampsia resolves after delivery of the fetus, but patients may still have hypertension postpartum. Women and fetuses affected by preeclampsia are at higher risk of developing long-term health issues. There appear to be risk factors common to hypertensive disorders of pregnancy and cardiovascular disease seen later in adulthood. Physicians providing healthcare to women are urged to recognize potential risk factors that arise from patient obstetric histories so that optimal long-term health surveillance is provided.

KW - Cardiovascular disease

KW - Hypertension

KW - Preeclampsia

KW - Pregnancy

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=84876878279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876878279&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2013.02.005

DO - 10.1053/j.ackd.2013.02.005

M3 - Article

VL - 20

SP - 287

EP - 296

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 3

ER -